FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520292384> ?p ?o ?g. }

• W1520292384 abstract "Introduction Intracranial aneurysms, especially those of the cavernous segment of the internal carotid artery (ICA), can present with cranial nerve palsies. Few studies exist reporting the outcomes of cranial neuropathies following treatment with the Pipeline Embolization Device (PED). Methods A prospectively maintained endovascular database was reviewed for all patients treated with the PED after presenting with one or more cranial nerve palsies secondary to a cerebral aneurysm since May 2011. Patient charts were reviewed to report clinical and angiographic outcomes. Only patients with clinical follow-up were included in the analysis. Results Since FDA approval, 127 patients were treated with the PED at our institution. Twenty-two patients presented with cranial neuropathies for initial inclusion in this study. Of these, 20 patients had sufficient follow-up for analysis. Cranial neuropathies included those of CN II, III, V, and VI, with presenting symptoms of diplopia, decreased visual acuity, and facial numbness/pain. Thirteen lesions were cavernous segment ICA aneurysms, whereas the remainder included supraclinoid and petrous segment ICA, posterior communicating artery and basilar trunk aneurysms. At a mean follow-up of 9.55 months, 15 patients (75%) had resolution or significant improvement of their cranial neuropathies and 5 had stable symptoms. Twelve (66.7%) of 18 patients with angiographic follow-up demonstrated complete obliteration or small neck residual, whereas 6 (30.0%) had residual lesion. Patients with complete/near-complete obliteration were significantly more likely to demonstrate symptomatic improvement at follow-up (p = 0.009). Two patients with persistent symptoms were eventually treated with microsurgical bypass. Complications in this series included six (30.0%) transient extracranial haemorrhagic complications related to antiplatelet therapy, and one delayed asymptomatic ICA occlusion following retreatment. Conclusion Treatment of intracranial aneurysms presenting with one or more cranial nerve palsies results in a high rate of clinical improvement after treatment with the PED. Clinical outcomes must be weighed against the risks and challenges faced with flow diverters. Disclosures K. Moon: None. F. Albuquerque: None. A. Ducruet: None. R. Crowley: None. C. McDougall: None." @default.
• W1520292384 created "2016-06-24" @default.
• W1520292384 creator A5022788776 @default.
• W1520292384 creator A5039738713 @default.
• W1520292384 creator A5057048902 @default.
• W1520292384 creator A5067286956 @default.
• W1520292384 creator A5071741375 @default.
• W1520292384 date "2014-07-01" @default.
• W1520292384 modified "2023-09-27" @default.
• W1520292384 title "O-003 Resolution of Cranial Neuropathies Following Treatment of Intracranial Aneurysms with the Pipeline Embolization Device" @default.
• W1520292384 doi "https://doi.org/10.1136/neurintsurg-2014-011343.3" @default.
• W1520292384 hasPublicationYear "2014" @default.
• W1520292384 type Work @default.
• W1520292384 sameAs 1520292384 @default.
• W1520292384 citedByCount "0" @default.
• W1520292384 crossrefType "journal-article" @default.
• W1520292384 hasAuthorship W1520292384A5022788776 @default.
• W1520292384 hasAuthorship W1520292384A5039738713 @default.
• W1520292384 hasAuthorship W1520292384A5057048902 @default.
• W1520292384 hasAuthorship W1520292384A5067286956 @default.
• W1520292384 hasAuthorship W1520292384A5071741375 @default.
• W1520292384 hasConcept C126838900 @default.
• W1520292384 hasConcept C141071460 @default.
• W1520292384 hasConcept C2776035437 @default.
• W1520292384 hasConcept C2776098176 @default.
• W1520292384 hasConcept C2778034410 @default.
• W1520292384 hasConcept C2778333808 @default.
• W1520292384 hasConcept C2780581723 @default.
• W1520292384 hasConcept C71924100 @default.
• W1520292384 hasConceptScore W1520292384C126838900 @default.
• W1520292384 hasConceptScore W1520292384C141071460 @default.
• W1520292384 hasConceptScore W1520292384C2776035437 @default.
• W1520292384 hasConceptScore W1520292384C2776098176 @default.
• W1520292384 hasConceptScore W1520292384C2778034410 @default.
• W1520292384 hasConceptScore W1520292384C2778333808 @default.
• W1520292384 hasConceptScore W1520292384C2780581723 @default.
• W1520292384 hasConceptScore W1520292384C71924100 @default.
• W1520292384 hasLocation W15202923841 @default.
• W1520292384 hasOpenAccess W1520292384 @default.
• W1520292384 hasPrimaryLocation W15202923841 @default.
• W1520292384 hasRelatedWork W1804545398 @default.
• W1520292384 hasRelatedWork W1982540399 @default.
• W1520292384 hasRelatedWork W1987851908 @default.
• W1520292384 hasRelatedWork W2369408083 @default.
• W1520292384 hasRelatedWork W2371346845 @default.
• W1520292384 hasRelatedWork W2381335135 @default.
• W1520292384 hasRelatedWork W2383472831 @default.
• W1520292384 hasRelatedWork W2394749858 @default.
• W1520292384 hasRelatedWork W2414262935 @default.
• W1520292384 hasRelatedWork W2419092717 @default.
• W1520292384 hasRelatedWork W2797077990 @default.
• W1520292384 hasRelatedWork W2908526621 @default.
• W1520292384 hasRelatedWork W2963691844 @default.
• W1520292384 hasRelatedWork W2969433644 @default.
• W1520292384 hasRelatedWork W3015142703 @default.
• W1520292384 hasRelatedWork W3029426830 @default.
• W1520292384 hasRelatedWork W3029681034 @default.
• W1520292384 hasRelatedWork W3213930374 @default.
• W1520292384 hasRelatedWork W1866780208 @default.
• W1520292384 hasRelatedWork W2123006793 @default.
• W1520292384 isParatext "false" @default.
• W1520292384 isRetracted "false" @default.
• W1520292384 magId "1520292384" @default.
• W1520292384 workType "article" @default.